RAR Antibodies

Santa Cruz Biotechnology features a diverse variety of RAR Antibodies for understanding retinoic acid receptors. Monoclonal RAR Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Retinoic acid receptors play a crucial role in mediating the effects of retinoic acid, which is essential for regulating gene expression, cellular differentiation, and development. RAR signaling pathways are fundamental in maintaining cellular homeostasis and tissue development. Research has shown that RAR expression patterns vary across different tissues and developmental stages. Understanding RAR function continues to reveal new possibilities in cancer research and therapeutic development. Investigating RAR mechanisms provides valuable insights into developmental processes and disease progression. Current studies focusing on RAR signaling are uncovering promising therapeutic applications. Santa Cruz Biotechnology monoclonal RAR Antibodies support researchers worldwide in advancing scientific understanding of retinoic acid receptor biology.